Close Menu

Amgen

After a survey of UK oncologists revealed that access hurdles and high costs associated with biomarker testing are limiting their ability to prescribe personalized treatments, Merck Serono has issued a "call to action" for the government and pharmaceutical industry to work togeth

By Uduak Grace Thomas
Researchers at Life Technologies and the Indiana University School of Medicine have published an informatics approach for detecting cancer gene fusions in RNA sequencing data from SOLiD sequencers.

Dako, Amgen Ink CDx Deal for Undisclosed Oncologic
Dako and Amgen announced they will partner to develop a companion diagnostic for an undisclosed oncology drug that Amgen is currently advancing in clinical trials.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Dako said on Monday that it has entered into an additional collaboration with Amgen to develop a companion diagnostic for an Amgen cancer drug candidate.

Qiagen Expands Companion Diagnostic Portfolio
Qiagen has received approval of its Therascreen EGFR Mutation Detection Kit RGQ from Japanese regulatory authorities.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Dako said today that it will collaborate with Amgen to develop a diagnostic test for a drug candidate for treating a rare and deadly form of cancer.

Pages

The Atlantic reports another SARS-CoV-2 testing problem may be lurking: backlogs.

Researchers have sequenced the genome of "the Methuselah of freshwater fish."

The US Biomedical Advanced Research and Development Authority is supporting efforts to develop vaccines against SARS-CoV-2.

In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.